- Our Company
- Our Strategy
- Governance
- Sustainability
- Sustainable and Equitable Access to Healthcare
- Environmental Impact and Healthcare Systems’ Resilience
- Code of Conduct and Responsible Business
- Animals in Research and Production
- Information on Dengvaxia®
- Information on Sodium Valproate
- ESG Index
- Downstream Emissions to the Environment
- Circular Economy & Waste Management
- Industrial Emissions to the Environment
- Eco-design
- Climate
- Water
- Biodiversity
- Soil and Groundwater Remediation
- Health and Safety
- Pricing
- Sustainable and Equitable Access to Healthcare
- Human Rights
- Political Engagement
- Information Security and Data Privacy
- Tax Disclosures
- Responsible Promotion and Marketing of Products
- Animal Care and Use
- Bioethics and Clinical Trials
- Product Quality and Patient Safety
- Risk Management
- Sustainable Procurement
- Ethics & Business Integrity
- Bioethics Framework
- Principles on Clinical Study Transparency
- Principles on Gene Therapy and Genome Editing
- Principle on Collection, Storage and Use of Human Biological Samples for Research
- Principles on Representation in Human Clinical Trials
- Principles on Compassionate Use of Sanofi Investigational Products
- Principles on Data Ethics
- Principles on Post-Trial Access to Investigational Products
- Principles on Responsible Use of Genetic Resources
- Diversity, Equity, and Inclusion In and Beyond the Workplace
- A Million Conversations
- Allyship
- Employee Resource Groups
- Diversity, Equity and Inclusion Board
- Gender Balance
- LGBTQ+
- Global Health Unit
- Our Legacy
- Our Science
- Our Pipeline
- Our R&D Focus
- Immunology R&D
- Neurology R&D
- Oncology R&D
- Rare Blood Disorders R&D
- Rare Diseases R&D
- Vaccines R&D
- Artificial Intelligence in R&D
- Technology Platforms
- Clinical Trials & Results
- Our Data-Sharing Commitments
- Clinical Study Results
- Investigator Sponsored Studies
- Diversity in Clinical Trials
- Scientific Collaboration
- Scientific Collaboration in North America
- External Innovation in Europe
- Scientific Collaboration in China
- Digital & AI
- Manufacturing and Supply
- Your Health
- Vaccines & Infectious Diseases
- Dengue
- Diphtheria
- Haemophilus influenzae type b infections
- Hepatitis A
- Hepatitis B
- Influenza
- Meningococcal Meningitis
- Pertussis
- Poliomyelitis
- Rabies
- Respiratory Syncytial Virus (RSV)
- Tetanus
- Typhoid fever
- Why Vaccines Matter
- Yellow fever
- Medicines
- Immunology
- Neurology
- Oncology
- Rare Blood Disorders
- Rare Diseases
- Cardiovascular Diseases
- Diabetes
- Transplant
- Patient Engagement
- Healthcare Professionals Support
- Partnering
- Partnering Focus Areas
- China
- Digital
- General Medicines
- Immunology
- Neuroscience
- Oncology
- Out-Licensing
- Rare Disease
- Technology Platforms
- Vaccines
- Meet the Partnering Team
- Oncology Golden Ticket
- Stories
- Media
- Investors
- News and Events
- Results and Presentations
- Conferences
- Shares, ADRs and Bonds
- Share Price
- Dividend
- Shares, Structure and Vote
- Bonds
- Analyst Coverage and Vara Consensus
- Share Repurchases
- American Depositary Receipts
- Financial Reports and Other Publications
- Tender offer by Sanofi to acquire Ablynx
- Environment, Social, Governance
- Regulated information
- Private Shareholders
- Contacts and Subscription
- Shareholder publications
- Legal notice
- Our publications
- Directory
- Sanofi US Privacy Policies